Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ü. Ölmez, P. Garred, T. E. Mollnes, M. Harboe, H. B. Berntzen & E. Munthe. (1991) C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 20:3, pages 183-189.
Read now
Read now
G. T. Espersen, B. Langeland & N. Grunnet. (1990) Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA). Scandinavian Journal of Clinical and Laboratory Investigation 50:4, pages 389-393.
Read now
Read now
G. T. Espersen, E. Ernst, M. Vestergaard, J. O. Pedersen & N. Grunnet. (1989) Changes in PMN Leukocyte Migration Activity and Complement C3d Levels in RA Patients with High Disease Activity during Steroid Treatment. Scandinavian Journal of Rheumatology 18:1, pages 51-56.
Read now
Read now
P. Bjork, L. Axelsson, M. Bergenfeldt & K. Ohlsson. (1988) Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man. Scandinavian Journal of Clinical and Laboratory Investigation 48:2, pages 205-211.
Read now
Read now
Articles from other publishers (20)
Karolina Förnvik Jonsson, Emma Liljedahl, Kurt Osther, Johan Bengzon, Lillemor Melander Skattum & Henrietta Nittby Redebrandt. (2023) Complement Components in Peripheral Blood from Adult Patients with IDH Wild-Type Glioblastoma. World Neurosurgery 177, pages e742-e747.
Crossref
Crossref
Claus Lohman Brasen, Henry Christensen, Dorte A. Olsen, Søren Kahns, Rikke F. Andersen, Jeppe B. Madsen, Amanda Lassen, Helene Kierkegaard, Anders Jensen, Thomas V. Sydenham, Jonna S. Madsen, Jens K. Møller & Ivan Brandslund. (2021) Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19. Clinical Chemistry and Laboratory Medicine (CCLM) 59:12, pages 1988-1997.
Crossref
Crossref
Thurid Ahlenstiel-Grunow, Svenja Hachmeister, Franz Christoph Bange, Cyrill Wehling, Michael Kirschfink, Carsten Bergmann & Lars Pape. (2016)
Systemic complement activation and complement gene analysis in enterohaemorrhagic
Escherichia coli
-associated paediatric haemolytic uraemic syndrome
. Nephrology Dialysis Transplantation 31:7, pages 1114-1121.
Crossref
Crossref
A. Foltyn Zadura, E. Theander, A. M. Blom & L. A. Trouw. (2009) Complement Inhibitor C4b-Binding Protein in Primary Sjögren’s Syndrome and its Association With Other Disease Markers. Scandinavian Journal of Immunology 69:4, pages 374-380.
Crossref
Crossref
Kenneth Ahrend Petersen, Finn Matthiesen, Teit Agger, Leif Kongerslev, Steffen Thiel, Karen Cornelissen & Mads Axelsen. (2006) Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin. Journal of Clinical Immunology 26:5, pages 465-475.
Crossref
Crossref
Michelle S ChewVibeke Brix-Christensen, Hanne B Ravn, Ivan Brandslund, Emmy Ditlevsen, Jens Pedersen, Kirsten Hjortholm, Ole K Hansen, Else Tùnnesen & Vibeke E Hjortdal. (2016) Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion 17:5, pages 327-333.
Crossref
Crossref
EVA LeinØE, ANDRA PachaÏ & IVAN Brandslund. (2008) Complement activation reaches maximum during equilibrium between antigen and antibody in an in vitro model for thrombolysis with streptokinase. APMIS 108:10, pages 685-688.
Crossref
Crossref
ANDRA PACHAÏI, ANNE KIILERICH ERLENDSSON & IVAN BRANDSLUND. (1997) Streptokinase, complement activation and hypotension. APMIS 105:7-12, pages 650-654.
Crossref
Crossref
P. STORGAARD, E. HOLM NIELSEN, E. SKRIVER, O. ANDERSEN & S.‐E. SVEHAG. (2006) Mannan‐Binding Protein Forms Complexes with α‐2‐Macroglobulin. A Proposed Model for the Interaction. Scandinavian Journal of Immunology 42:3, pages 373-380.
Crossref
Crossref
Magnus Bergenfeldt & Kjell Ohlsson. (1993) Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis. Gastroenterologia Japonica 28:5, pages 687-698.
Crossref
Crossref
Hans-Olof Håkansson & Kjell Ohlsson. (1992) Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins. Gastroenterologia Japonica 27:5, pages 652-656.
Crossref
Crossref
Hiroyuki Kitajima, Masanori Fujimura, Toru Takeuchi, Akira Miyano, Masahiro Nakayama, Tomio Fujita, Shirou Imai & Akira Shimizu. (1990) Effect of amnionitis on the complement system of preterm infants. Early Human Development 21:1, pages 59-69.
Crossref
Crossref
H. E. NIELSEN, K. C. CHRISTENSEN, C. KOCH, B. S. THOMSEN, N. H. H. HEEGAARD & J. TRANUM‐JENSEN. (2006) Hereditary, Complete Deficiency of Complement Factor H Associated with Recurrent Meningococcal Disease. Scandinavian Journal of Immunology 30:6, pages 711-718.
Crossref
Crossref
M. DELSHAMMAR, Å. LASSON, I.-M. NILSSON, K. OHLSSON, A. WALLMARK & E. VERNERSSON. (1989) Abnormal proteolysis (DIC)-successful treatment with antithrombin III concentrate and a concentrate containing F XIII and native von Willebrand factor. Journal of Internal Medicine 225:1, pages 21-27.
Crossref
Crossref
P. GARRED, T. E. MOLLNES & T. LEA. (2006) Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3. Scandinavian Journal of Immunology 27:3, pages 329-335.
Crossref
Crossref
P. GARRED, T. E. MOLLNES, T. LEA & E. FISCHER. (2006) Characterization of a Monoclonal Antibody MoAb bH6 Reacting with a Neoepitope of Human C3 Expressed on C3b, iC3b, and C3c. Scandinavian Journal of Immunology 27:3, pages 319-327.
Crossref
Crossref
C. Kock-Jensen, I. Brandslund & I. S�gaard. (1988) Lumbar disc surgery and variations in C-reactive protein, erythrocyte sedimentation rate and the complement split product C 3 d. Acta Neurochirurgica 90:1-2, pages 42-44.
Crossref
Crossref
Åke Lasson, Magnus Delshammar & Kjell Ohlsson. 1988. Proteases II. Proteases II
433
440
.
I. BRANDSLUND, H. H. W. IBSEN, N. A. KLITGAARD, S.‐E. SVEHAG, E. SIMONSEN & H. DIEDERICHSEN. (2009) Plasma Concentrations of Complement Split Product C3d and Immune Complexes after Procainamide Induced Production of Antinuclear Antibodies. Acta Medica Scandinavica 220:5, pages 431-435.
Crossref
Crossref
YOUVAL MLYNEK & MARIANNE NILSSON. (2009) THE QUANTITATION OF C3d BY ROUTINE METHODS AFTER THE DIRECT ABSORPTION OF HUMAN PLASMA WITH ANTI-C3c. Acta Pathologica Microbiologica Scandinavica Series C: Immunology 93C:1-6, pages 195-198.
Crossref
Crossref